Patents by Inventor Caroline Coriat

Caroline Coriat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20160193166
    Abstract: The use of substance selected from taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis, for preventing or inhibiting the undesirable side-effects caused to a human or an animal organism by an active ingredient that induces a high level of extracellular GABA or increases GABA receptor activation, and a pharmaceutical composition including the substance and the active ingredient.
    Type: Application
    Filed: February 23, 2016
    Publication date: July 7, 2016
    Inventors: Serge PICAUD, Jose Alain SAHEL, Jammoul FIRAS, Caroline CORIAT, Manuel SIMONUTTI
  • Anticonvulsive pharmaceutical compositions
    Patent number: 9308260
    Abstract: The use of substance selected from taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis, for preventing or inhibiting the undesirable side-effects caused to a human or an animal organism by an active ingredient that induces a high level of extracellular GABA or increases GABA receptor activation, and a pharmaceutical composition including the substance and the active ingredient.
    Type: Grant
    Filed: July 4, 2008
    Date of Patent: April 12, 2016
    Assignee: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Serge Picaud, Jose Alain Sahel, Jammoul Firas, Caroline Coriat, Manuel Simonutti
  • ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100184707
    Abstract: The use of a substance selected from the group consisting of taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the taurine biosynthesis, for manufacturing a pharmaceutical composition for preventing or inhibiting the undesirable side-effects caused to a human or an animal organism by an active ingredient that induces a high level of extracellular GABA or increases GABA receptor activation.
    Type: Application
    Filed: July 4, 2008
    Publication date: July 22, 2010
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Serge Picaud, Jose Alain Sahel, Jammoul Firas, Caroline Coriat, Manuel Simonutti